Murine studies and expressional analyses of human cardiac pericytes reveal novel trajectories of SARS-CoV-2 Spike protein-induced microvascular damage
Open Access
- 2 June 2023
- journal article
- letter
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculatureCardiovascular Research, 2022
- The state of complement in COVID-19Nature Reviews Immunology, 2021
- The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular diseaseClinical Science, 2021
- Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyteCardiovascular Diabetology, 2021
- COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targetsNature, 2021
- Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographicsNature Medicine, 2021
- Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern ItalyJournal of the American Heart Association, 2020
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, ChinaJAMA Cardiology, 2020
- Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 Mediated MyocarditisCirculation, 2020
- Transcriptional and Cellular Diversity of the Human HeartCirculation, 2020